Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine dose comparison in nasal endoscopic surgery under local anesthesia
ChiCTR-TRC-14004886Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in chronic rhinosinusitis (CRS) (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoints: Blood pressure, Heart rate and 1 more. Started Sep 2014; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ChiCTR-TRC-14004886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004886.